How Bad Are Your Sinus Symptoms?

What is the SNOT-22?

The Sino-Nasal Outcome Test (SNOT-22) is the most widely used patient-reported outcome measure for chronic rhinosinusitis worldwide. It was developed by rhinology researchers and has been validated in multiple languages across dozens of clinical studies. When ENTs and allergists need to objectively measure how severely sinus disease is affecting a patient's quality of life, this is the tool they use. It is also used in clinical trials evaluating sinus medications and surgical interventions, which means the ranges and thresholds have strong clinical evidence behind them.

The test covers 22 items across four domains: rhinological symptoms (nasal blockage, discharge, sneezing, loss of smell), ear and facial symptoms (ear fullness, dizziness, facial pain), sleep function (difficulty sleeping, waking at night, fatigue), and psychological impact (reduced productivity, reduced concentration, frustration, sadness, embarrassment). This breadth is what makes the SNOT-22 more informative than simply asking "how stuffy is your nose?" It captures the full downstream impact of sinus disease on your life.

How to interpret your score

Scores of 0 to 20 indicate mild sinus symptoms. Your sinuses are functional, drainage is adequate, and the impact on sleep, energy, and daily function is minimal. If you scored in this range and are not currently on treatment, your sinuses are managing well. If you scored in this range while on treatment, your treatment is effective.

Scores of 21 to 50 indicate moderate chronic rhinosinusitis. At this level, sinus symptoms are noticeable and are beginning to affect your daily function. You likely have persistent congestion, post-nasal drip, and some sleep disruption. Sinus pressure episodes may occur regularly. Medical management (nasal corticosteroid sprays, saline irrigation, allergy treatment if allergies are contributing) typically provides significant improvement at this severity level. Many patients in this range have been living with their symptoms for years without realizing that effective treatment exists.

Scores of 51 to 80 indicate severe chronic rhinosinusitis. Sinus disease at this level is substantially impairing your quality of life across multiple domains. Sleep is disrupted. Daytime fatigue and reduced concentration affect work performance. Facial pain or pressure may be frequent. The emotional toll (frustration, sadness, embarrassment about constant nose blowing and throat clearing) is significant. This severity typically requires specialist evaluation. An allergist determines whether allergic inflammation is driving the sinus obstruction. An ENT evaluates for structural contributors (nasal polyps, deviated septum, narrowed sinus openings) that may benefit from surgical correction.

Scores of 81 to 110 indicate very severe chronic rhinosinusitis. Every domain is heavily affected. Sleep deprivation is profound. Cognitive function is impaired. Emotional well-being is significantly compromised. Patients at this level are often unable to function normally and may have been through multiple rounds of antibiotics without lasting improvement. Prompt comprehensive evaluation (allergy testing, nasal endoscopy, CT imaging, and ENT consultation) is warranted. Treatment at this severity often involves a combination of medical management (steroids, allergy treatment, immunotherapy) and potentially surgical intervention (functional endoscopic sinus surgery) to address both the inflammatory and structural components of the disease.

The allergy connection to chronic sinus disease

In Central Texas, allergic inflammation is one of the most common drivers of chronic sinusitis. The mechanism is straightforward: allergic swelling of the nasal lining blocks the small openings (ostia) through which the sinuses drain. When mucus cannot drain, it accumulates inside the sinus cavity. Stagnant mucus becomes a breeding ground for bacteria, leading to sinus infections. Each infection causes additional inflammation and potential scarring. Over years, this cycle of allergic obstruction, mucus stagnation, and secondary infection produces the chronic sinus disease that the SNOT-22 measures.

The implication is that treating the allergy often improves the sinus disease, because removing the upstream cause (allergic swelling) restores the downstream function (sinus drainage). Patients who have been on the antibiotic merry-go-round for recurrent sinus infections frequently find that allergy treatment (nasal steroids, allergen avoidance, immunotherapy) breaks the cycle by keeping the sinus drainage openings from swelling shut in the first place.

This is why allergy testing is a valuable part of any chronic sinusitis evaluation. If allergies are driving the inflammation, treating them is more effective and more sustainable than treating each downstream infection as it occurs. The SNOT-22 score can track the improvement: patients who start comprehensive allergy treatment often see their scores drop substantially over the first season of treatment.

How the SNOT-22 is used clinically

Beyond initial assessment, the SNOT-22 is valuable for tracking treatment response over time. A score at baseline, then repeated at three months, six months, and annually, shows whether your treatment plan is moving the needle. Clinicians look for a change of at least 8.9 points (the "minimally clinically important difference" established in research) to confirm that a treatment has produced a real, perceptible improvement.

For surgical decision-making, the SNOT-22 helps both the patient and surgeon understand the expected benefit. Studies show that patients with higher pre-operative SNOT-22 scores tend to have greater absolute improvement after surgery, because there is more room for improvement. A patient with a pre-operative score of 65 who drops to 20 after surgery has experienced a transformative change. The pre-operative score also helps set realistic expectations: a patient with a score of 25 may improve with surgery, but the absolute magnitude of improvement will be smaller because the starting point is lower.

If you are considering sinus surgery and your surgeon has not administered the SNOT-22, you can bring your score from this online assessment to your consultation. It gives both of you a shared starting point for the discussion about whether surgery is likely to make a meaningful difference in your specific case.

Practical steps based on your score

If you scored mild (0-20): Continue current management. Maintain nasal steroid use during your allergy seasons. Use saline irrigation for sinus maintenance. Monitor for worsening.

If you scored moderate (21-50): Start or optimize nasal corticosteroid spray (daily, consistent use). Begin regular saline irrigation if you have not already. Consider allergy testing to identify whether allergic triggers are contributing to your sinus inflammation. These steps alone often bring moderate scores into the mild range within weeks.

If you scored severe (51-80): Schedule an allergy evaluation. Start nasal steroids and saline irrigation immediately while waiting for your appointment. Your allergist may order CT imaging and refer to an ENT if structural issues are suspected. Immunotherapy should be discussed if allergies are a significant contributor.

If you scored very severe (81-110): Seek evaluation promptly. This level of sinus disease is significantly impairing your health and function. A combined approach (allergist for inflammatory management, ENT for structural evaluation) provides the most comprehensive path to improvement. Do not wait for the next sinus infection to get evaluated. At this severity, the underlying disease process requires proactive treatment, not reactive antibiotics.